Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate Cancer

PURPOSE: To assess whether the cellular proliferation marker Ki67 provides prognostic information and predicts response to radiation therapy fractionation in patients with localized prostate tumors participating in a randomized trial of 3 radiation therapy fractionation schedules (74 Gy/37 fractions...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilkins, Anna C., Gusterson, Barry, Szijgyarto, Zsolt, Haviland, Joanne, Griffin, Clare, Stuttle, Christine, Daley, Frances, Corbishley, Catherine M., Dearnaley, David P., Hall, Emma, Somaiah, Navita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Inc 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947826/
https://www.ncbi.nlm.nih.gov/pubmed/29559283
http://dx.doi.org/10.1016/j.ijrobp.2018.01.072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947826/
https://www.ncbi.nlm.nih.gov/pubmed/29559283
http://dx.doi.org/10.1016/j.ijrobp.2018.01.072

Ejemplares similares